A. Gandorfer et al., Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane, RETINA, 20(2), 2000, pp. 126-133
Citations number
18
Categorie Soggetti
Optalmology
Journal title
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Purpose: To evaluate the surgical results of pars plana vitrectomy with pee
ling of the inner limiting membrane (ILM) in a preliminary series of 12 eye
s with diffuse diabetic macular edema.
Patients and Methods: Pars plana vitrectomy with peeling of the ILM was per
formed in 12 eyes with diffuse diabetic macular edema. In 10 eyes, the post
erior hyaloid was attached and thickened. Six eyes had undergone macular ph
otocoagulation previously, and two other eyes had been vitrectomized previo
usly. Light and electron microscopy of the specimens obtained during vitrec
tomy was performed. Visual acuity and retinal thickening were monitored,
Results: Intraoperatively, the posterior hyaloid was found to be thickened
and completely attached to the macula in 10 eyes, Two previously vitrectomi
zed eyes showed a glistening reflex of the vitreoretinal interface but no p
remacular membrane, The posterior hyaloid and the ILM were removed from the
macula, Postoperatively, retinal thickening resolved or decreased in all e
yes. Visual acuity improved by at least two lines in 11 eyes, Best-correcte
d postoperative visual acuity developed within 4 to 12 weeks. No recurrence
or deterioration of macular edema or epiretinal membrane formation were ob
served during the entire period of review (mean, 16 months; range, 8-31 mon
ths), Light and electron microscopy showed the presence of the ILM associat
ed with sparse and mostly single-layered fibrous astrocytes.
Conclusion: Vitrectomy including removal of the ILM leads to expedited reso
lution of diffuse diabetic macular edema and improvement of visual acuity w
ithout subsequent epiretinal membrane formation, Complete release of tracti
onal forces and inhibition of reproliferation of fibrous astrocytes seem to
be prudent in the eyes of patients with diabetes and advanced vitreoretina
l interface disease of the macula.